Genetic testing accuracy: needle biopsy vs. surgery
Part of Cancer, Hormones & metabolism clinical trials.
This study compares genetic testing results from a small needle biopsy to those from the surgically removed thyroid tissue. It aims to see if the biopsy alone can accurately predict the cancer's genetics, which could help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a thyroid nodule that is larger than 1 cm (about the size of a pea) on imaging.
- Your biopsy showed either a high suspicion for cancer (Bethesda V or VI) or an uncertain result (Bethesda III or IV) with specific genetic changes.
- You are healthy enough for surgery (thyroidectomy).
- You have not had radiation to your neck in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a genetic test called GuidePx® helps doctors plan surgery for thyroid cancer. It may help avoid unnecessary surgeries by guiding the best treatment for each person.
This trial studies the genetic “mutations” in papillary thyroid cancer tumors using tumor tissue. The goal is to better describe tumor genetic patterns, which may help researchers understand the disease.
This study looks at thyroid biopsy samples that were 'suspicious' for cancer. It tests a special marker (BRAF V600E) to see if it can help tell whether the suspicious cells are actually cancer, which may improve diagnosis.
This study tests a new tool (ThyroidPrint) to see if it can accurately predict whether a thyroid nodule with unclear biopsy results is benign or malignant. The goal is to help doctors and patients decide on surgery more confidently.
This study compares a less invasive procedure (microwave ablation) with traditional surgery for treating a small, low-risk papillary thyroid cancer. If you have a single, small tumor with certain low-risk gene changes, you might be able to avoid surgery and have a quicker recovery.
This study looks at patient tissue from needle biopsies to see if DNA “methylation” patterns can help diagnose and guide treatment for thyroid nodules. You might benefit by helping improve how these nodules are evaluated, using information from your biopsy sample and medical data.
Hear when a new Papillary Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.